LigoCyte Pharmaceuticals Inc — Form D
LigoCyte Pharmaceuticals Inc of Bozeman, MT, a company, filed a Form D exempt-offering notice with the SEC on 2010-04-22. The offering totals $14.5M, of which $6.5M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2010-04-22
- Form: D
- Accession: 0001400794-10-000001
- Industry: Pharmaceuticals
- Exemptions: 06
- Total offering: $14.5M
- Amount sold: $6.5M
- Remaining: $8.0M
- Minimum investment: $20K
- Investors: 11
- Date of first sale: 2010-04-09
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-140972
Issuer
- Name: LigoCyte Pharmaceuticals Inc
- CIK: 0001400794
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2008
- Address: 2155 Analysis Drive, Bozeman, MT, 59718
- Phone: 406-585-2733
Officers, directors & promoters (20)
| Name | Role | Location |
|---|
| Ivor Royston | Director | La Jolla, CA |
| Ben Auspitz | Director | Cambridge, MA |
| C. Boyd Clarke | Director | Madison, WI |
| C. Boyd Clarke | Executive Officer | Madison, WI |
| ROBERT GOODWIN | Executive Officer | BOZEMAN, MT |
| Ivor Royston, M.D. | Director | Waltham, MA |
| Larry Mikkola | Executive Officer | Bozeman, MT |
| Donald Beeman | Director | Bozeman, MT |
| Donald Beeman | Executive Officer | Bozeman, MT |
| J. Donald deBethizy | Director | Winston, NC |
| Hironori Boyd Hozoji | Director | Tokyo, M0 |
| Markus Boyd Goebel | Director | Bozeman, MT |
| Hironori Hozoji | Director | Tokyo, M0 |
| George Boyd Kemble | Director | Bozeman, MT |
| Rob Goodwin | Executive Officer | Bozeman, MT |
| George Kemble, Ph.D. | Director | Bozeman, MT |
| Donald P Beeman | Director | Bozeman, MT |
| Donald P Beeman | Executive Officer | Bozeman, MT |
| J. Donald deBethizy, Ph.D. | Director | Bozeman, MT |
| Markus Goebel, M.D., Ph.D. | Director | Bozeman, MT |
Other filings by this issuer (4)
More